David Elkins V.
EVP, Chief Financial Officer at Bristol-Myers Squibb; Director at Tapestry. Based in New York, New York.
- Rank
- 8531st of 14,644
- Companies held
- 2
- Largest holding
- BMY, 89.5% of total
- Latest SEC filing
- Nov 11, 2026
What the $10.4M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Bristol-Myers Squibb BMY Common Stock, $0.10 par value | Directly | 159,248 | $58.34 | $9.3M | 89.3% | Form 4, Apr 1, 2026 |
| Tapestry TPR Common Stock | Directly | 8,872 | $123.68 | $1.1M | 10.5% | Form 4, Nov 11, 2026 |
| Bristol-Myers Squibb BMY Common Stock, $0.10 par value | BMS Savings and Investment Program | 294 | $58.34 | $17K | 0.2% | Form 4, Apr 1, 2026 |
Share counts are the amounts David Elkins V. reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 8528 | Ann Mather Director, Alphabet. Austin, TX | $10.4M |
| 8529 | Michael G. Erickson Executive Vice President, IDEXX Laboratories. Westbrook, ME | $10.4M |
| 8530 | Edward Infantolino Director, Parke Bancorp. Sewell, NJ | $10.4M |
| 8531 | David Elkins V. EVP, Chief Financial Officer, Bristol-Myers Squibb. New York, NY | $10.4M |
| 8532 | Melissa M. Tomkiel Co-CEO and General Counsel, Strata Critical Medical. New York, NY | $10.4M |
| 8533 | David Flavell EVP, Gen Counsel & Corp Sec, PepsiCo. Purchase, NY | $10.4M |
| 8534 | Karen James Executive Vice President and, BancFirst. Oklahoma City, OK | $10.4M |
Other Bristol-Myers Squibb insiders
All BMY insiders- Sandra Leung$27.1MEVP, General Counsel. #3989 overall
- Giovanni Caforio$25.2MExecutive Chair of the Board. #4159 overall
- Paul von Autenried$9.3MEVP, Chief Information Officer. #9258 overall
- Christopher Boerner$8.7MChief Executive Officer. #9674 overall
- Theodore R. Samuels II$2.2MDirector. #9490 overall
- Michael R. McMullen$58KDirector. #2678 overall
Questions
How much stock does David Elkins V. own?
David Elkins V. holds $10,404,994 in listed stock based on SEC filings and current prices, mostly Bristol-Myers Squibb (BMY). That ranks 8531st on the Stock Rich List.
Is this David Elkins V.'s net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did David Elkins V. last buy or sell stock?
The most recent open-market trade on file is a sale of 25,519 BMY shares on Apr 1, 2026 at $61.60.